Lyell Immunopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Lynn Seely

CEOLynn Seely

Employees

300

Employees300

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

300

Employees300

LYEL Key Statistics

Market cap

138.90M

Market cap138.90M

Price-Earnings ratio

-0.38

Price-Earnings ratio-0.38

Dividend yield

—

Dividend yield—

Average volume

39.47K

Average volume39.47K

High today

$9.75

High today$9.75

Low today

$9.24

Low today$9.24

Open price

$9.62

Open price$9.62

Volume

23.97K

Volume23.97K

52 Week high

$35.80

52 Week high$35.80

52 Week low

$7.65

52 Week low$7.65

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.